Article Versions Notes

Marijan S, Mastelić A, Markotić A, Režić-Mužinić N, Vučenović N, Barker D, Pilkington LI, Reynisson J, Čulić VČ. Thieno[2,3-b]Pyridine Derivative Targets Epithelial, Mesenchymal and Hybrid CD15s⁺ Breast Cancer Cells. Medicines. 2021; 8(7):32. https://doi.org/10.3390/medicines8070032

Marijan, Sandra, Angela Mastelić, Anita Markotić, Nikolina Režić-Mužinić, Nikolina Vučenović, David Barker, Lisa I. Pilkington, Jóhannes Reynisson, and Vedrana Čikeš Čulić. 2021. "Thieno[2,3-b]Pyridine Derivative Targets Epithelial, Mesenchymal and Hybrid CD15s⁺ Breast Cancer Cells" Medicines 8, no. 7: 32. https://doi.org/10.3390/medicines8070032

Marijan, S., Mastelić, A., Markotić, A., Režić-Mužinić, N., Vučenović, N., Barker, D., Pilkington, L. I., Reynisson, J., & Čulić, V. Č. (2021). Thieno[2,3-b]Pyridine Derivative Targets Epithelial, Mesenchymal and Hybrid CD15s⁺ Breast Cancer Cells. Medicines, 8(7), 32. https://doi.org/10.3390/medicines8070032